BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3917980)

  • 1. In vitro evidence that human airway lysozyme is cleaved and inactivated by Pseudomonas aeruginosa elastase and not by human leukocyte elastase.
    Jacquot J; Tournier JM; Puchelle E
    Infect Immun; 1985 Feb; 47(2):555-60. PubMed ID: 3917980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa elastase does not inactivate alpha 1-proteinase inhibitor in the presence of leukocyte elastase.
    Padrines M; Bieth JG
    Infect Immun; 1989 Dec; 57(12):3793-7. PubMed ID: 2509370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor.
    Morihara K; Tsuzuki H; Oda K
    Infect Immun; 1979 Apr; 24(1):188-93. PubMed ID: 110691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase.
    Catanese J; Kress LF
    Biochim Biophys Acta; 1984 Aug; 789(1):37-43. PubMed ID: 6432051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa.
    Sponer M; Nick HP; Schnebli HP
    Biol Chem Hoppe Seyler; 1991 Nov; 372(11):963-70. PubMed ID: 1686554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The propeptide of Pseudomonas aeruginosa elastase acts an elastase inhibitor.
    Kessler E; Safrin M
    J Biol Chem; 1994 Sep; 269(36):22726-31. PubMed ID: 8077225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that Pseudomonas aeruginosa elastase does not inactivate the bronchial inhibitor in the presence of leukocyte elastase. Studies with cystic fibrosis sputum and with pure proteins.
    Tournier JM; Jacquot J; Puchelle E; Bieth JG
    Am Rev Respir Dis; 1985 Sep; 132(3):524-8. PubMed ID: 2412473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase.
    Heck LW; Morihara K; McRae WB; Miller EJ
    Infect Immun; 1986 Jan; 51(1):115-8. PubMed ID: 3079727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Lysozyme Peptidase Resistance Is Perturbed by the Anionic Glycolipid Biosurfactant Rhamnolipid Produced by the Opportunistic Pathogen Pseudomonas aeruginosa.
    Andersen KK; Vad BS; Scavenius C; Enghild JJ; Otzen DE
    Biochemistry; 2017 Jan; 56(1):260-270. PubMed ID: 27931094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease.
    Heck LW; Morihara K; Abrahamson DR
    Infect Immun; 1986 Oct; 54(1):149-53. PubMed ID: 3093382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial purification and characterization of an inactive precursor of Pseudomonas aeruginosa elastase.
    Kessler E; Safrin M
    J Bacteriol; 1988 Mar; 170(3):1215-9. PubMed ID: 3125153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of an active fragment of the LasA protein from Pseudomonas aeruginosa: enhancement of elastase activity.
    Peters JE; Galloway DR
    J Bacteriol; 1990 May; 172(5):2236-40. PubMed ID: 2110137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa elastase (LasB) as a therapeutic target.
    Everett MJ; Davies DT
    Drug Discov Today; 2021 Sep; 26(9):2108-2123. PubMed ID: 33676022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of human plasma alpha 1-proteinase inhibitor and its inactivation by Pseudomonas aeruginosa elastase.
    Morihara K; Tsuzuki H; Harada M; Iwata T
    J Biochem; 1984 Mar; 95(3):795-804. PubMed ID: 6427201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of basement membranes by Pseudomonas aeruginosa elastase.
    Bejarano PA; Langeveld JP; Hudson BG; Noelken ME
    Infect Immun; 1989 Dec; 57(12):3783-7. PubMed ID: 2509368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of Pseudomonas aeruginosa elastase, human leukocyte elastase and cathepsin G activities by micellar electrokinetic chromatography.
    Viglio S; Luisetti M; Zanaboni G; Döring G; Worlitzsch D; Cetta G; Iadarola P
    J Chromatogr A; 1999 Jun; 846(1-2):125-34. PubMed ID: 10420604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alginate, the slime exopolysaccharide of Pseudomonas aeruginosa, binds human leukocyte elastase, retards inhibition by alpha 1-proteinase inhibitor, and accelerates inhibition by secretory leukoprotease inhibitor.
    Ying QL; Kemme M; Simon SR
    Am J Respir Cell Mol Biol; 1996 Aug; 15(2):283-91. PubMed ID: 8703486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.
    Döring G; Goldstein W; Röll A; Schiøtz PO; Høiby N; Botzenhart K
    Infect Immun; 1985 Sep; 49(3):557-62. PubMed ID: 3928491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase.
    Falciani C; Lozzi L; Scali S; Brunetti J; Bracci L; Pini A
    Amino Acids; 2014 May; 46(5):1403-7. PubMed ID: 24510250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of sputum IgA and elastase on tracheal cell bacterial adherence.
    Niederman MS; Merrill WW; Polomski LM; Reynolds HY; Gee JB
    Am Rev Respir Dis; 1986 Feb; 133(2):255-60. PubMed ID: 3080931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.